Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Delayed Bombay S.E. 10:23:30 03/09/2026 BST			5-day change	1st Jan Change
2,948.00 ^INR	+0.05%		-3.92%	+19.31%

08-03	GSK India first-quarter profit rises on steady vaccine demand	RE
08-03	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	499,172	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	29.04%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	499,172	499,172
Change	-	-18.99%	58.51%	48.08%	-20.64%	29.04%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	42.8x	37.2x
PBR	10.6x	12.9x	18.5x	25x	17.1x	18.8x	15.8x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.4x	2.5x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	11.7x	10.6x
EV / Revenue	0x	0x	0x	0x	0x	11.7x	10.6x
EV / EBITDA	0x	0x	0x	0x	0x	33.6x	29.2x
EV / EBIT	0x	0x	0x	0x	0x	34x	29.2x
EV / FCF	0x	0x	0x	0x	0x	41.6x	37.9x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.4%	2.64%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1%	1%
EPS ²	100	36.05	34.83	54.76	61.15	68.78	79.18
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	42.9%	37.3%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	42,568	47,241
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,836	17,070
EBIT ¹	7,592	7,385	8,390	11,106	12,428	14,698	17,112
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,654	13,418
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,946.60	2,946.60
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	16/05/22	17/05/23	17/05/24	13/05/25	13/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	42.84x	-	-	1%	5.28B
ELI LILLY AND COMPANY	33.02x	11.99x	24.32x	0.6%	1,034B
JOHNSON & JOHNSON	30.61x	-	-	1.95%	663B
ABBVIE INC.	33.41x	7.74x	16.08x	2.62%	462B
ROCHE HOLDING AG	19.46x	4.63x	11.48x	2.86%	344B
NOVARTIS AG	22.94x	5.89x	14.62x	2.7%	307B
ASTRAZENECA PLC	20.8x	4.27x	12.2x	2.06%	251B
AMGEN INC.	28.01x	7.21x	12.82x	2.28%	239B
NOVO NORDISK A/S	13.44x	4.86x	10.14x	3.75%	207B
GILEAD SCIENCES, INC.	-45.71x	6.59x	25.73x	2.2%	186B
Average	19.88x	6.65x	15.92x	2.2%	369.87B
Weighted average by Cap.	24.36x	8.05x	17.83x	1.94%